Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...

Q4 Revenue consensus of $242.03M Q4 EPS consensus of $0.27 Fourth Quarter of Fiscal Year 2025 Outlook (in millions, except per share data) Net sales $ 250.0 +/- $5.0 Non-GAAP Financial Measures ...

The versatile DF-26 boasts the range and numbers to hit a variety of targets, from island outposts to American aircraft carriers and warships. Last fall, the US Department of Defense released its ...

The outcome? A wave of downgrades to forward earnings per share (EPS) forecasts for FY25 and FY26. In simpler terms, the anticipated EPS for most top-listed companies in these financial years now lags ...

Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, ...

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the ...

Adjusted EPS of $0.93 outperformed the analyst estimate of $0.81. Q3 revenue reached $1.01 billion, exceeding analyst forecasts of $982 million and reflecting a 29% year-over-year increase.

The DF-26 is a versatile missile with a range capable of threatening US forces across the Western Pacific. The US has indicated a need to harden air bases and disperse its forces to defend against ...

The central government may soon raise the wage ceiling under the Employees’ Provident Fund (EPF) scheme from Rs 15,000 to Rs 21,000, impacting contributions towards EPF and the Employees’ Pension ...

26 November Constitution Day: November 26, is also Samvidhan Divas, or Constitution Day, the day when, 125 years ago, India adopted her brilliantly crafted, almost flawless Constitution ...

11月26日，无锡兴达EPS报盘下调：普通料现金含税出厂报10950元/吨，阻燃料现金含税出厂报11150元/吨，价格较上一报价日下调50 ...

Earnings per share (EPS) of $2.75 exceeded the $2.68 estimate. Q3 comparable sales grew by 4.2%, significantly above last year's 1.9%. Inventory levels increased by 13%, a potential signal of ...